Skip to main navigationSkip to main content
The University of Southampton
Institute for Life Sciences

Bioengineering Seminar Series Event

18 January 2019
Room 4025, Building 53, Highfield Campus

Event details

‘Nanotechnologies for Advanced Drug Delivery Systems’ by Dr Michael Chen, University of Edinburgh

Abstract -  The market for advanced drug delivery systems is rising rapidly, because both clinical therapy and basic biological research rely on novel and innovative delivery techniques. In this seminar, I would like to introduce our research development in innovating and improving nanotechnologies based drug delivery, including diamond nanoneedle arrays for high-throughput intracellular delivery, and nanoparticles for enhanced cancer therapy and tumour imaging.     

Biography - Dr Michael Chen received his MSc and PhD from National University of Singapore, and University of Oxford, respectively. Subsequently, he worked in the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland as a postdoc and research fellow and then the Department of Physics and Materials Science at the City University of Hong Kong as an assistant professor. He is currently working in the Institute for Bioengineering in the School of Engineering at The University of Edinburgh as a Lecturer. Dr Chen’s research is focused on biomaterials, biomedical engineering, and the application of nanomaterials in biology and medicine. In these areas, he has been working on physical (microneedle & nanoneedle arrays) and chemical (nanomaterials) tools for drug delivery, bioimaging and sensing. He has published over 90 papers in peer-reviewed journals, majority in field top journals including Nature Communications, Advanced Materials, Angewandte Chemie International Edition, Advanced Functional Materials, Small, Advanced Healthcare Materials, Journal of the American Chemical Society, Nano Letters, ACS Nano, Biomaterials, Journal of Controlled Release, Advanced Drug Delivery Reviews, and Chemical Society Reviews. These publications generated an h-index of 37 and >3500 citations. Additionally, he has 2 book chapters and 9 granted patents & 18 patent applications in drug delivery technologies in major countries and regions, mostly in the USA and Europe. Some of these technologies have been invested by venture companies for commercialisation. For scientific community service, he serves as a reviewer for many field top journals and a number of research councils' grant proposals. Additionally, he serves as an Associate Editor of IET Nanobiotechnology and Editorial Board Member of Sensor.



We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.